The study is to evaluate a drug called Dexmedetomidine in reducing stress and anxiety levels for patients who are afraid of undergoing surgical extraction of lower impacted third molars.

Evaluation of Anxiolytic and Analgesic effect of Intranasal spray of Dexmedetomidine in patients undergoing surgical removal of impacted mandibular third molar: A Randomised Clinical Trial - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090580

Enrollment

Registered

2025-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dexmedetomidine: reduces the anxiety level in patient before undergoing surgery. dose= 0.7mcg/kg given intranasal administered only once before the procedure according to patients weigh

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to give informed consent Patients who are anxious ASA class I patients Patients who on evaluation have moderate surgical difficulty score on Pederson index

Exclusion criteria

Exclusion criteria: Patients not willing to participate Patients with systemic illness Patients already on longterm sedatives or analgesic use Patients with acute rhinitis upper respiratory tract infection cvs diseases and allergy to dexmedetomidine Pregnant or lactating females

Design outcomes

Primary

Measure	Time frame
reduction in anxiety and stress levelsTimepoint: 30 minutes	—

Secondary

Measure	Time frame
reduction in anxiety and stress levelsTimepoint: 30 minutes	—

Countries

India

Contacts

Public ContactRupinder Kaur

KAHER KLE VKIDS Belagavi

sanjsamuel@yahoo.com9845454266

Outcome results